Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.36

+1.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cheryl Galt who wrote (27761)	2/2/1999 11:10:00 AM
From: J Stone	Read Replies (2) of 32384

Cheryl, I agree that the probability of a takeover is remote; however, the idea got me thinking about a couple scenarios. Suppose Targretin proves to be as effective or more effective than Tamoxifen at treating breast cancer. If you're BMY (at least I think it's BMY) and you control rights to Tamoxifen and it's 1 of your largest cash generators, you're going to take action if possible to protect yourself. (BMY has aggressively protected Taxol production with special legislation and making deals with the likes of CYPH). The key for BMY would be that it can't wait too long to act. If the public finds out about the effectiveness of Targetin, the price of LGND would increase 8 to 10 fold (like ENMD). Consequently, they may have to gamble and place a bet early. Anyway, as we both agree, a takeover is unlikely; but, the thought of one is very intriguing. Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next